Theratechnologies Files March 2025 Report (6-K)
| Field | Detail |
|---|---|
| Company | Theratechnologies Inc. |
| Form Type | 6-K |
| Filed Date | Mar 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, press-release, foreign-private-issuer
Related Tickers: THTX
TL;DR
Theratechnologies filed a 6-K for March 2025, including a press release. Check for updates.
AI Summary
Theratechnologies Inc. filed a Form 6-K on March 26, 2025, reporting for the month of March 2025. The filing includes a press release dated March 25, 2025, as Exhibit 99.1. The company is based in Montreal, Canada, and its fiscal year ends on November 30.
Why It Matters
This filing provides an update on Theratechnologies' activities and includes a press release, which may contain material information for investors.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that primarily contains a press release and does not appear to disclose significant new financial or operational risks.
Key Players & Entities
- Theratechnologies Inc. (company) — Registrant
- March 25, 2025 (date) — Press Release Date
- March 26, 2025 (date) — Filing Date
- Jocelyn Lafond (person) — General Counsel and Corporate Secretary
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report for the month of March 2025 and to include a press release dated March 25, 2025, as an exhibit.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed with the SEC on March 26, 2025.
What is the principal executive office of Theratechnologies Inc.?
The principal executive office of Theratechnologies Inc. is located at 2015 Peel Street, Suite 1100, Montreal, Quebec, H3A 1T8, Canada.
Does Theratechnologies Inc. file annual reports under Form 20-F or Form 40-F?
Theratechnologies Inc. files annual reports under Form 20-F, as indicated by the checkmark next to 'Form 20-F'.
Who signed this report on behalf of Theratechnologies Inc.?
The report was signed by Jocelyn Lafond, General Counsel and Corporate Secretary, on behalf of Theratechnologies Inc.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 26, 2025 by Jocelyn Lafond regarding Theratechnologies Inc..